CAPRICOR THERAPEUTICS, INC. (CAPR) Operating cash flow 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$69.8MFY2025 · since FY2016: -$14.5M → -$69.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$69.8M | -74.5% |
| FY2024 | -$40.0M | -56.3% |
| FY2023 | -$25.6M | -620.6% |
| FY2022 | $4.9M | +129.2% |
| FY2021 | -$16.8M | -67.2% |
| FY2020 | -$10.1M | -47.4% |
| FY2019 | -$6.8M | +50.8% |
| FY2018 | -$13.9M | +2.6% |
| FY2017 | -$14.2M | +1.5% |
| FY2016 | -$14.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice